搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Vibrio cholerae serotype O1 Na (+)-translocating NADH-quinone reductase subunit E, partial CSB-YP399386VEY1
CSB-EP399386VEY1
CSB-BP399386VEY1
CSB-MP399386VEY1
CSB-EP399386VEY1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 N utilization substance protein B homolog (nusB) CSB-YP399387VEY
CSB-EP399387VEY
CSB-BP399387VEY
CSB-MP399387VEY
CSB-EP399387VEY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Lipid-A-disaccharide synthase (lpxB) CSB-YP399388VEY
CSB-EP399388VEY
CSB-BP399388VEY
CSB-MP399388VEY
CSB-EP399388VEY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 UPF0294 protein VC0395_A1830/VC395_2354 (VC0395_A1830, VC395_2354) CSB-YP399389VEY
CSB-EP399389VEY
CSB-BP399389VEY
CSB-MP399389VEY
CSB-EP399389VEY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Vibriobactin receptor (viuA), partial CSB-YP399390VEY
CSB-EP399390VEY
CSB-BP399390VEY
CSB-MP399390VEY
CSB-EP399390VEY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Flagellin E (flaE) CSB-YP399391VEY
CSB-EP399391VEY
CSB-BP399391VEY
CSB-MP399391VEY
CSB-EP399391VEY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Ferric uptake regulation protein (fur) CSB-YP399392VEY
CSB-EP399392VEY
CSB-BP399392VEY
CSB-MP399392VEY
CSB-EP399392VEY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Phosphate acyltransferase (plsX) CSB-YP399393VEY
CSB-EP399393VEY
CSB-BP399393VEY
CSB-MP399393VEY
CSB-EP399393VEY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Bifunctional protein FolD (folD) CSB-YP399394VEY
CSB-EP399394VEY
CSB-BP399394VEY
CSB-MP399394VEY
CSB-EP399394VEY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Integration host factor subunit beta (ihfB) CSB-YP399395VEY
CSB-EP399395VEY
CSB-BP399395VEY
CSB-MP399395VEY
CSB-EP399395VEY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Tetraacyldisaccharide 4'-kinase (lpxK) CSB-YP399396VEY
CSB-EP399396VEY
CSB-BP399396VEY
CSB-MP399396VEY
CSB-EP399396VEY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Holliday junction ATP-dependent DNA helicase RuvA (ruvA) CSB-YP399397VEY
CSB-EP399397VEY
CSB-BP399397VEY
CSB-MP399397VEY
CSB-EP399397VEY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Putative N-acetylmannosamine-6-phosphate 2-epimerase (nanE) CSB-YP399398VEY
CSB-EP399398VEY
CSB-BP399398VEY
CSB-MP399398VEY
CSB-EP399398VEY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Glycogen synthase (glgA) CSB-YP399399VEY
CSB-EP399399VEY
CSB-BP399399VEY
CSB-MP399399VEY
CSB-EP399399VEY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Probable intracellular septation protein A (VC0395_A1304, VC395_1818), partial CSB-YP399400VEY1
CSB-EP399400VEY1
CSB-BP399400VEY1
CSB-MP399400VEY1
CSB-EP399400VEY1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Putative ribosomal RNA large subunit methyltransferase F (rlmF) CSB-YP399401VEY
CSB-EP399401VEY
CSB-BP399401VEY
CSB-MP399401VEY
CSB-EP399401VEY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Dihydroorotate dehydrogenase (quinone) CSB-YP399402VEY
CSB-EP399402VEY
CSB-BP399402VEY
CSB-MP399402VEY
CSB-EP399402VEY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Ribosomal RNA large subunit methyltransferase I (rlmI) CSB-YP399403VEY
CSB-EP399403VEY
CSB-BP399403VEY
CSB-MP399403VEY
CSB-EP399403VEY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 50S ribosomal protein L27 (rpmA) CSB-YP399404VEY
CSB-EP399404VEY
CSB-BP399404VEY
CSB-MP399404VEY
CSB-EP399404VEY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Lipoprotein signal peptidase (lspA), partial CSB-YP399405VEY1
CSB-EP399405VEY1
CSB-BP399405VEY1
CSB-MP399405VEY1
CSB-EP399405VEY1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>